Pyridoxal 5'-Phosphate
Thorne

Pyridoxal 5'-Phosphate

C+
N+ Score75
Vitamins & MineralsServing: 1 Capsule(s)Type: Vitamin

Thorne Pyridoxal 5'-Phosphate is a focused vitamin supplement containing 33.8 mg of Vitamin B6 (as P-5-P) per capsule. This specific form and dosage of Vitamin B6 are considered clinically adequate, supporting its potential role in metabolic processes. The product has an N+ Score of 75, resulting in a C+ grade, reflecting good quality through its precise dosing and complete label transparency. As a single-ingredient formula with one active component, its formula completeness is rated accordingly. This supplement is designed for those looking to specifically enhance their Vitamin B6 intake.

About This Product

Pyridoxal 5'-Phosphate by Thorne is a vitamins & minerals supplement containing 1 active ingredients. It has earned an N+ Score of 75/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin B6.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity36/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Limited ingredient diversity compared to category norms

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
Vitamin B633.800 mgOptimal

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.